[go: up one dir, main page]

Zhang et al., 2013 - Google Patents

Increased incidence of narcolepsy following the 2009 H1N1 pandemic

Zhang et al., 2013

View HTML
Document ID
1194256828380031409
Author
Zhang X
Penzel T
Han F
Publication year
Publication venue
Somnologie-Schlafforschung und Schlafmedizin

External Links

Snippet

Narcolepsy is an autoimmune sleep disease characterized by excessive daytime sleepiness, cataplexy, and intrusive rapid eye movement sleep. Deficit in endogenous orexin is a major pathogenic component of the disease. This disorder is also associated with …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Similar Documents

Publication Publication Date Title
Sarkanen et al. Narcolepsy associated with Pandemrix vaccine
Fernandes et al. Saliva in the diagnosis of COVID-19: a review and new research directions
Partinen et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland
De la Herran-Arita et al. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy
Lin et al. Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease
Sheridan et al. Obesity is associated with impaired immune response to influenza vaccination in humans
Del Porto et al. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis: safety and immunogenicity
Ollila et al. HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy
Guerrieri et al. Nasal and salivary mucosal humoral immune response elicited by mRNA BNT162b2 COVID-19 vaccine compared to SARS-CoV-2 natural infection
Keskin et al. Physical detection of influenza A epitopes identifies a stealth subset on human lung epithelium evading natural CD8 immunity
Norouzirad et al. Serum levels of anti-hepatitis B surface antibody among vaccinated population aged 1 to 18 years in ahvaz city southwest of iran
Urano et al. COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions
Mazaheri-Tehrani et al. Borna disease virus (BDV) infection in psychiatric patients and healthy controls in Iran
Muehling et al. Circulating memory CD4+ T cells target conserved epitopes of rhinovirus capsid proteins and respond rapidly to experimental infection in humans
Thwaites et al. Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine
Gottfredsson et al. Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections
Hsieh et al. Durability and immunogenicity of neutralizing antibodies response against omicron variants after three doses of subunit SARS-CoV-2 vaccine MVC-COV1901: an extension to an open-label, dose-escalation phase 1 study
Kim et al. Sequential emergence and wide spread of neutralization escape Middle East respiratory syndrome coronavirus mutants, South Korea, 2015
Philippot et al. Autoantibodies neutralizing type I IFNs in the bronchoalveolar lavage of at least 10% of patients during life-threatening COVID-19 pneumonia
Smith-Norowitz et al. Long-term persistence of IgE anti-influenza A HIN1 virus antibodies in serum of children and adults following influenza A vaccination with subsequent H1N1 infection: a case study
US20240133898A1 (en) Compositions and methods for identification of cross-reactive allergenic proteins and treatment of allergies
Hansen et al. Antibody‐dependent neutralizing capacity of the SARS‐CoV‐2 vaccine BNT162b2 with and without previous COVID‐19 priming
Hsieh et al. T cells in multisystem inflammatory syndrome in children (MIS-C) have a predominant CD4+ T helper response to SARS-CoV-2 peptides and numerous virus-specific CD4− CD8− double-negative T cells
Buonocore et al. Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?
Zhang et al. Increased incidence of narcolepsy following the 2009 H1N1 pandemic